— Psychiatry News and Insights

An accelerated form of intermittent theta-burst stimulation showed a significant reduction in depression among individuals with treatment-resistant bipolar disorder, according to findings from a small randomized clinical trial. (JAMA Psychiatry)

A decade after receiving cognitive behavioral therapy (CBT), older adults suffering from both anxiety and depression still saw 58% of participants in remission from all diagnoses. (Journal of Affective Disorders)

Following the EAT-Lancet diet, which is heavily plant-based and emphasizes vegetables, fruits, whole grains, and nuts, was linked to a decreased risk of developing depression, anxiety, or experiencing both conditions together. (Nature Communications)

A large study of nearly 12,000 clinicians revealed significant differences in how they approached care for patients with major depressive disorder. (JAMA Psychiatry)

Indivior announced that it plans to phase out its risperidone extended-release injectable (Perseris), used for treating schizophrenia.

One psychiatrist’s approach to discussing gender identity with transgender youth offers insights into navigating these sensitive conversations. (New York Times)

A study analyzing 1,600 samples revealed that children diagnosed with autism spectrum disorder possess a distinct gut microbiome composition. (Nature Microbiology)

The use of levonorgestrel-releasing intrauterine systems (IUS) has been associated with a dose-dependent increased risk of depression among first-time users. (American Journal of Psychiatry)

Significant variability was found in the impact of antipsychotic medications on bodyweight, BMI, triglycerides, cholesterol levels, prolactin, heart rate, and systolic blood pressure in children and adolescents. (Lancet Child & Adolescent Health)

The Biden administration has allocated $27.5 million in funding to improve behavioral health care for women.

New York City is making efforts to keep its mental health clubhouses operational. (Gothamist)